We are live on ! Find out more
DRIO icon

DarioHealth
DRIO

21 hedge funds and large institutions have $5.65M invested in DarioHealth in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

0.17% more ownership

Funds ownership: 11.54% → 11.72% (+0.17%)

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

16% less capital invested

Capital invested by funds: $6.76M → $5.65M (-$1.1M)

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$141K
2
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust
Pennsylvania
+$54.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$28.5K
4
Morgan Stanley
Morgan Stanley
New York
+$14.9K
5
Osaic Holdings
Osaic Holdings
Arizona
+$14.1K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$117K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$28.6K
3
TRCT
Tower Research Capital (TRC)
New York
-$3.59K
4
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
-$1.75K
5
SS
SBI Securities
Japan
-$15

DRIO Hedge Fund Activity: Q2 2026 in Review

21 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2026, worth a combined $5.65M — down 16% from $6.76M a quarter earlier.

Fund positioning in DRIO was balanced in Q2 2026: 2 funds opened new positions, 2 closed out, 8 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $141K. The largest seller was UBS Group, cutting an estimated $117K.

  • 21 institutional investors held DarioHealth (DRIO) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $5.65M of DarioHealth stock for Q2 2026, down 16% quarter-over-quarter.
  • 2 funds opened new DarioHealth positions in Q2 2026 and 2 closed out, a net change of 0 holders.
  • The largest DarioHealth buyer in Q2 2026 was BlackRock, an estimated $141K added.
  • The largest DarioHealth seller in Q2 2026 was UBS Group, an estimated $117K sold.

Based on aggregated 13F filings for Q2 2026.